The risks and rewards of gene-editing
Robin Lovell-Badge, developmental biologist and geneticist, talks to FT science columnist Anjana Ahuja about the gene-edited babies controversy in China and about the potential for new gene-editing techniques to transform the treatment of diseases like cancer and muscular dystrophy. Hosted on Acast. See…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like FT Tech Tonic →
The extraordinary promise of gene editing
If We Can Make Genetically Engineered Designer Babies - Should We?
The age of genetic wonder | Juan Enriquez
Why Gene-Edited Babies May Be Closer Than Ever
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.